4//SEC Filing
Francis Knuettel II 4
Accession 0001753926-24-001576
CIK 0001919246other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:55 PM ET
Size
7.6 KB
Accession
0001753926-24-001576
Insider Transaction Report
Form 4
Francis Knuettel II
CFO, Treas & Secty
Transactions
- Purchase
Common Stock
2024-09-12$0.97/sh+1,700$1,649→ 544,210 total(indirect: By Trust) - Purchase
Common Stock
2024-09-13$0.97/sh+3,500$3,395→ 547,710 total(indirect: By Trust)
Footnotes (2)
- [F1]This transaction is being reported to reflect the purchase of these shares by the Lara Knuettel Revocable Trust, of which the Reporting Person is co-trustee and has individual dispositive power. This price represents the weighted average price of the shares purchased ranging from $0.93 to $0.98 per share, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- [F2]This transaction is being reported to reflect the purchase of these shares by the Lara Knuettel Revocable Trust, of which the Reporting Person is co-trustee and has individual dispositive power. This price represents the weighted average price of the shares purchased ranging from $0.94 to $0.98 per share, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Documents
Issuer
Chromocell Therapeutics Corp
CIK 0001919246
Entity typeother
Related Parties
1- filerCIK 0001433316
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 4:55 PM ET
- Size
- 7.6 KB